KRAS and neoplasm: In our study, after assessing the interval time between the two KRAS analyses (primary tumor and corresponding CRLM), it was interesting to note that intra-tumoral heterogeneity was significantly more frequently documented during the first 6 months from the time of primary tumor evaluation.